— Know what they know.
Not Investment Advice

256840.KQ KOE

BNC Korea Co., Ltd.
1W: +19.7% 1M: +13.3% 3M: +17.7% YTD: -32.6% 1Y: -38.6% 3Y: -5.7% 5Y: -58.6%
₩3,155.00 ($2.35)
-120.00 (-3.66%)
 
Weekly Expected Move ±17.9%
₩2025 ₩2590 ₩3155 ₩3720 ₩4285
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 57 · ₩215.8B mcap · 55M float · 2.84% daily turnover

Cash Flow Trends

Operating Cash Flow
$16.7B +1.6% ▲
5Y CAGR: +34.6%
Capital Expenditures
$18.1B -119.1% ▼
5Y CAGR: +18.2%
Free Cash Flow
-$1.4B -116.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$22.4B +149.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$1.4B-$176.3B-$44.7B$17.7B$15.7B
Depreciation & Amort.$1.9B$2.9B$5.1B$8.1B$9.3B
Stock-Based Comp.$0$393M$472M$472M$79M
Change in Working Capital-$681M-$3.0B-$1.8B-$3.6B-$8.0B
Other Non-Cash Items$1.3B$164.7B$35.4B-$6.3B-$333M
Operating Cash Flow$3.9B-$11.3B-$5.5B$16.4B$16.7B
— Investing Activities —
Capital Expenditures-$31.8B-$8.4B-$19.2B-$8.3B-$14.5B
Acquisitions (Net)$4M$0-$13.8B-$2.0B$2.0B
Investment Purchases-$70M-$170M-$4.0B-$19.6B-$9.8B
Investment Sales$22M$15M$380M$378M$13.0B
Other Investing-$175M$0$514M-$14.4B-$3.2B
Investing Cash Flow-$32.0B-$8.6B-$36.2B-$43.9B-$12.5B
— Financing Activities —
Net Debt Issuance$12.8B$44.9B-$11.9B-$15.5B$11.0B
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$494M-$5.5B-$17.7B-$2.7B-$1.9B
Financing Cash Flow$13.6B$44.4B$123.6B-$18.2B$15.6B
Net Change in Cash-$15.0B$24.6B$82.0B-$45.6B$22.4B
Cash End of Period$7.4B$32.1B$114.0B$68.4B$90.8B
Free Cash Flow-$27.9B-$19.7B-$24.7B$8.2B-$1.4B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms